Spondyloarthritis

Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

December 1, 2022 • By Walter P. Maksymowych, MB ChB, FACP, FRCP(C)

Challenges in Psoriatic Arthritis

November 29, 2022 • By Samantha C. Shapiro, MD

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

November 29, 2022 • By Ashley Krivohlavek

From Denial of Spondyloarthritis to a Support Group Leader & Medical Doctor of Rheumatology: A Patient’s Perspective

November 29, 2022 • By Shung Ming Chiu, MD

Treat to Target in axSpA

November 29, 2022 • By Samantha C. Shapiro, MD

Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

November 18, 2022 • By David S. Pisetsky, MD, PhD

FDA Approves Upadacitinib for Non-Radiographic Axial Spondyloarthritis

October 27, 2022 • By Michele B. Kaufman, PharmD, BCGP

Ankylosing Spondylitis: Treat to Target

October 18, 2022 • By From the College

Article – GAM Native Ad Test

October 11, 2022 • By University of South Florida Rheumatology Fellowship Program: Anastasiya (Stacy) Bagrova, MD; Shreya Gor, MD; Joanne Valeriano-Marcet, MD; Larry Young, MD; & John Carter, MD

Sacroiliitis on MRI: axSpA or Another Cause?

August 31, 2022 • By Arthritis & Rheumatology